Natac Natural Ingredients, S.A. (NAT) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Natac Natural Ingredients, S.A. €0.06, price €0.56, upside -89.2%, quality 27 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.
How to read this chart
60‑month range €0.4460 – €0.9500 · the €0.5550 price screens above the €0.0600 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 4, 2026.
Follow Natac Natural Ingredients in your weekly email
Every Wednesday you see whether Natac Natural Ingredients is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Natac Natural Ingredients, S.A. engages in producing sustainable natural ingredients from botanicals and fish in Europe, Asia, Latam, North America, and internationally. It offers its products to nutraceutical, animal feed, pet nutrition, pharmaceutical, food, and cosmetics industries. The company was formerly known as IFFE Futura, S.A.
Show more
Natac Natural Ingredients, S.A. engages in producing sustainable natural ingredients from botanicals and fish in Europe, Asia, Latam, North America, and internationally. It offers its products to nutraceutical, animal feed, pet nutrition, pharmaceutical, food, and cosmetics industries. The company was formerly known as IFFE Futura, S.A. Natac Natural Ingredients, S.A. was incorporated in 2011 and is headquartered in Getafe, Spain.
Stock analysis
Natac Natural Ingredients, S.A. (NAT) currently trades at €0.5550, while our model-based Fair Value estimate is €0.0600, 89.2% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of €0.1100 per share, and 0 of the 12 models we run sit above the €0.5550 price.
Bear case: the Multiples group reads lowest at €0.0400, and 12 of the 12 models stay below the price. Evidence for this calculation is low.
Quality & growth
The Quality Score stands at 27/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Natac Natural Ingredients, S.A. reported revenue of €48.0M in FY2026 versus €1.1M in FY2022, a compound +158.6%/yr. Reported net income was €1.1M in FY2026, compounding +90.4%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.
Key figures
Market cap €240M · P/S ratio 5.01 · Net margin 2.2% · Return on equity 2.4% · Return on assets (EBIT) 1.4% · Operating margin 25.1% · Revenue (TTM) €47.8M · Revenue growth (YoY) +95.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (medium confidence).
What moves the price
The share trades about 38% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at −89%, NAT screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (€0.0200 to €0.1600). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear €0.0600Fair Value €0.0600Bull €0.0600
Price €0.5550 · Upside -89.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+33.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+116.3%
Start year 2021 (pandemic). Over 10 years: +70.8% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+57.1%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
−18.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−18.1%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.34% → 9%
Compare Natac Natural Ingredients, S.A. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 713 stocks
Beats the industry median on 3/12 measures
Overall it trails its industry peers.
Valuation
Quality Score27 · Bottom 25%
Fair Value upside−89.2% · Bottom 25%
Profitability
Return on equity (TTM)2.4% · Below median
Return on assets1.8% · Below median
Net margin (TTM)2.2% · Below median
Operating margin (TTM)25.1% · Top 25%
Growth and dividend
Revenue growth95.3% · Top 25%
Balance sheet
Debt / equity1.02× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/B5.99× · Priciest 25%
P/S (TTM)5.64× · Priciest 25%
EV/EBITDA36.4× · Priciest 25%
PEG0.45× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 60
PAST (return on equity)10· sector 26
HEALTH (low debt)49· sector 95
DIVIDEND (yield)0· sector 28
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Natac Natural Ingredients, S.A. (NAT) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of €0.0600 versus a price of €0.5550, about −89% upside (overvalued).
What is the fair value of NAT?
Our model-based fair value for Natac Natural Ingredients, S.A. is €0.0600 (as of Oct 4, 2026), built from audited fundamentals. The current price: €0.5550.
What is the quality score of NAT?
Natac Natural Ingredients, S.A. has a Quality Score of 27/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Natac Natural Ingredients, S.A. (NAT)?
Our model-based price target is the fair value of €0.0600 (as of Oct 4, 2026) from 12 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Natac Natural Ingredients, S.A. stock forecast for 2026?
Our models put fair value at €0.0600, about −89% upside versus a price of €0.5550 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Natac Natural Ingredients, S.A. (NAT)?
Natac Natural Ingredients, S.A. reported trailing-twelve-month revenue of about €47.8M (latest available figure, as of Oct 4, 2026).
What is the intrinsic value of Natac Natural Ingredients, S.A. (NAT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Natac Natural Ingredients, S.A. it is €0.0600 per share (as of Oct 4, 2026), against a price of €0.5550. It is the blended result of 12 valuation models (cash flow, earnings, asset, dividend).
Is Natac Natural Ingredients, S.A. stock overvalued or undervalued in 2026?
As of Oct 4, 2026, NAT trades above its calculated fair value: price €0.5550, fair value €0.0600, a gap of about −89% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NAT?
No. The price is what the market pays today (€0.5550); the fair value is what the company's own numbers justify (€0.0600). For Natac Natural Ingredients, S.A. the two are €0.4950 per share apart. That gap is exactly why we show both numbers side by side.
How much is Natac Natural Ingredients, S.A. worth?
The market values Natac Natural Ingredients, S.A. at about €240M (market capitalisation, as of Oct 4, 2026). Per share that is €0.5550; our models calculate a fair value of €0.0600 per share.
What is the PEG ratio of NAT?
The PEG ratio of Natac Natural Ingredients, S.A. is 0.45 (P/E divided by earnings growth, as of Oct 4, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Natac Natural Ingredients, S.A. (NAT)?
Balance-sheet figures for Natac Natural Ingredients, S.A. (as of Oct 4, 2026): return on equity 2.4%, debt of 1.02 per unit of equity. They feed the Quality Score of 27/100, which measures business quality independently of the share price.
How far is NAT from its 52-week high?
Natac Natural Ingredients, S.A. trades at €0.5550, about 38% below its 52-week high of €0.8900 and 3% above the low of €0.5400 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of €0.0600 is for.
Which stocks are comparable to Natac Natural Ingredients, S.A.?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Natac Natural Ingredients, S.A. stock attractive at the current price?
The data as of Oct 4, 2026: price €0.5550, calculated fair value €0.0600 (−89%), Quality Score 27/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NAT calculated?
We run Natac Natural Ingredients, S.A. through 12 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €0.0600, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Natac Natural Ingredients, S.A. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Natac Natural Ingredients, S.A. (NAT)?
The closing price on Oct 2, 2026 was €0.5550. Our model-based fair value is €0.0600, about −89% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Natac Natural Ingredients, S.A. right now?
The price sits above even our optimistic bull case (€0.0600). The favourable scenario is already priced in. Weak quality (27/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Natac Natural Ingredients, S.A.
How large is the market capitalisation of Natac Natural Ingredients, S.A. (NAT)?
The market capitalisation of Natac Natural Ingredients, S.A. is €240M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Natac Natural Ingredients, S.A. (NAT)?
The price-to-sales ratio of Natac Natural Ingredients, S.A. is 5.01 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Natac Natural Ingredients, S.A. (NAT)?
The net margin of Natac Natural Ingredients, S.A. is 2.2% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Natac Natural Ingredients, S.A. (NAT)?
The return on equity (ROE) of Natac Natural Ingredients, S.A. is 2.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Natac Natural Ingredients, S.A. (NAT)?
On an EBIT basis the return on assets of Natac Natural Ingredients, S.A. is 1.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Natac Natural Ingredients, S.A. (NAT)?
The operating margin of Natac Natural Ingredients, S.A. is 25.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Natac Natural Ingredients, S.A. (NAT)?
Revenue at Natac Natural Ingredients, S.A. is growing +95.3% versus a year earlier (3y avg +28.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Natac Natural Ingredients, S.A. (NAT) generate?
The free cash flow of Natac Natural Ingredients, S.A. is −€7.4M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Natac Natural Ingredients, S.A. (NAT) carry?
The net debt of Natac Natural Ingredients, S.A. is €64.2M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Natac Natural Ingredients, S.A. in the live analysis
One click puts Natac Natural Ingredients, S.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
